---
layout: post
title: "浙江医药：ARX305获得药物临床试验申请受理通知书"
date: 2021-12-22 17:12:17 +0800
categories: emnews
tags: 东财滚动新闻
---
> 浙江医药(600216)12月22日晚间公告，公司在研药物注射用重组人源化抗CD70单抗-AS269偶联物(代号：ARX305)获得药物临床试验申请受理通知书。（证券时报）

<!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/1.600216" data-code="600216|1|1" data-code2="600216|1|2|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=1.600216&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 600216_0" data-code="K 600216|1|1" data-code2="K 600216|1|2|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p><span id="stock_1.600216"><a href="http://quote.eastmoney.com/unify/r/1.600216" class="keytip" data-code="1,600216">浙江医药</a></span><span id="quote_1.600216"></span>(600216)12月22日晚间<span id="Info.3332"><a href="http://data.eastmoney.com/notices/" class="infokey">公告</a></span>，公司在研药物注射用<span id="Info.3271"><a href="http://data.eastmoney.com/bgcz/" class="infokey">重组</a></span>人源化抗CD70单抗-AS269偶联物(代号：ARX305)获得药物临床试验申请受理通知书。 </p><p class="em_media">（文章来源：<span id="bk_90.BK0473"><a href="http://quote.eastmoney.com/unify/r/90.BK0473" class="keytip" data-code="90,BK0473">证券</a></span><span id="bkquote_90.BK0473"></span>时报）</p>

<http://finance.eastmoney.com/news/1354,202112222222860554.html>

[返回东财滚动新闻](//finews.withounder.com/emnews/)｜[返回首页](//finews.withounder.com/)